ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CYCCP Cyclacel Pharmaceuticals Inc

7.70
-0.30 (-3.75%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cyclacel Pharmaceuticals Inc CYCCP NASDAQ Acción Preferente
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.30 -3.75% 7.70 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.97 7.70 10.97 7.70 8.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/6/202407:00GLOBECyclacel’s Fadraciclib Demonstrates Efficacy in..
03/6/202407:00GLOBECyclacel Pharmaceuticals Reports New Clinical Data at 2024..
17/5/202408:56EDGAR2Form D - Notice of Exempt Offering of Securities
14/5/202416:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202415:05EDGAR2Form 8-K - Current report
14/5/202415:05GLOBECyclacel Pharmaceuticals Reports First Quarter Financial..
13/5/202415:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/5/202408:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
07/5/202420:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202420:52EDGAR2Form DEF 14A - Other definitive proxy statements
06/5/202416:26EDGAR2Form S-1 - General form for registration of securities under..
02/5/202415:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
30/4/202412:51APS$8 Million Private Placement Announcement Sends Biotech..
30/4/202406:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
01/4/202408:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
19/3/202415:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
13/3/202415:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
07/3/202408:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
06/3/202408:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
20/2/202408:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
14/2/202415:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/2/202409:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202416:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202408:15EDGAR2Form 8-K - Current report
30/1/202408:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
19/1/202415:58EDGAR2Form S-1 - General form for registration of securities under..
12/1/202415:05EDGAR2Form 8-K - Current report
10/1/202412:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202415:05EDGAR2Form 8-K - Current report
26/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202308:29EDGAR2Form 8-K - Current report
26/12/202308:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/12/202308:00GLOBECyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
12/12/202315:06EDGAR2Form 8-K - Current report
12/12/202315:05GLOBECyclacel Pharmaceuticals Announces Reverse Stock Split
30/11/202308:15GLOBECyclacel Regains Compliance With Nasdaq Listing Rule..
28/11/202320:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202320:20EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28/11/202316:15GLOBECyclacel Receives Notification of Deficiency From Nasdaq..
28/11/202315:59EDGAR2Form 8-K - Current report
15/11/202316:04EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/11/202316:03EDGAR2Form 8-K - Current report
13/11/202315:06EDGAR2Form 8-K - Current report
07/11/202315:10EDGAR2Form 8-K - Current report
07/11/202308:15GLOBECyclacel Pharmaceuticals to Release Third Quarter 2023..